Here are five insights:
1. In Q1 2017, Mazor received six Mazor X purchase orders in the United States. Two of these purchases represented trade-in orders from customers who previously bought the Renaissance system.
2. On the international sale, Mazor received a purchase order for a Renaissance brain module upgrade.
3. In Q1 2016, Mazor saw $6.4 million in revenue and received five Renaissance purchase orders.
4. Mazor has sold 40 Mazor X systems since its launch in the second half of 2016.
5. The company will report its Q1 financial results in May.
More articles on devices:
MicroPort Orthopedics launches system to help TKR patients — 5 takeaways
Integra expands credit facility to include $700M term loan — 4 details
Cutting mortality risk by shining light on osteoporosis & vertebral compression fracture treatment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
